Events
Featured Events
Join us at the Healthcare HR Summit 2026, taking place from May 14 to 15, 2026, at the prestigious Park Hyatt Aviara Resort, Golf Club & Spa in San Diego, CA. This invitation-only summit brings together senior-level healthcare HR executives and innovative solution providers to address critical industry challenges.
Experience insightful keynote presentations from industry leaders, including Michael Dowling, CEO Emeritus of Northwell Health, and Dr. Toby Cosgrove, former CEO and President of the Cleveland Clinic. Engage in real-life case studies and interactive forums designed to foster collaboration and strategic partnerships.
Don’t miss this opportunity to elevate your HR strategies and connect with peers in the healthcare sector.
Learn more now here: https://tinyurl.com/3ae7n3v5
Join us for the PharmaMarketing Summit 2026, an exclusive, invitation-only event tailored for senior pharmaceutical marketing executives and innovative service providers. This premier summit will feature industry leaders sharing insights on the latest trends and strategies in pharmaceutical marketing.
Key Speakers:
· Michael Silk, Vice President, Commercial Oncology, AbbVie
· Devika Gupta, Executive Director, Global Market Access, Immunology, Merck
· Kishan Kumar, Executive Director, Head of Marketing, Malignant Hematology, Novartis
The summit offers a unique opportunity for networking and collaboration, bringing together thought leaders to address key challenges and share innovative solutions in the pharmaceutical landscape. Don’t miss this chance to enhance your s…
The 9th Annual Global Clinical Trials Connect 2026 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, effective and quality…
Events
CPHI Middle East is a large-scale pharmaceutical event held in Riyadh, Saudi Arabia, connecting global and regional professionals in the pharmaceutical supply chain. The event brings together buyers, manufacturers, and suppliers from across the industry, from ingredients to finished products. It is a key platform for sourcing new business, gaining market insights, and fostering connections within the pharmaceutical sector in the Middle East and Africa.
Time: 9:00 AM - 6:00 PM
Venue Details: Riyadh Exhibition and Convention Center - Malham, Malham, Riyadh Province, 13380, Saudi Arabia
The 4th International Conference on ENT: Head and Neck Surgery will take place on May 11–12, 2026, in Kuala Lumpur, Malaysia. This premier global event will gather ENT specialists, otolaryngologists, surgeons, researchers, and healthcare professionals to exchange the latest innovations, research breakthroughs, and clinical practices in the field. Join us to network with industry leaders, present your work, and explore advancements in diagnosis, treatment, and surgical techniques in ENT and head and neck care.
We appreciate your response and looking forward to your collaboration
Regards,Luis ZaneConference ManagerLocation:1309 Coffeen Avenue, STE 1200Sheridan, Wyoming 82801, USA
Benchmark Existing Models and Interrogate Practical Applications of NAMs to Accelerate More Predictive In Vitro, In Vivo, and Computational ModelsWith nearly 90% of drug candidates failing in the clinic, and one-third of those failures driven by safety, toxicology has reached a critical inflection point. Traditional preclinical models are no longer sufficient to predict human risk, costing biopharma millions in late-stage attrition and stalled pipelines.
In 2026, toxicology enters a new era. The FDA's landmark 2025 roadmap to reduce reliance on animal testing has accelerated adoption of New Approach Methodologies (NAMs), including in vitro, microphysiological, and computational models. At the same time, CROs and technology developers are rapidly releasing new platforms, but uncertainty rem…
Join us at the Healthcare HR Summit 2026, taking place from May 14 to 15, 2026, at the prestigious Park Hyatt Aviara Resort, Golf Club & Spa in San Diego, CA. This invitation-only summit brings together senior-level healthcare HR executives and innovative solution providers to address critical industry challenges.
Experience insightful keynote presentations from industry leaders, including Michael Dowling, CEO Emeritus of Northwell Health, and Dr. Toby Cosgrove, former CEO and President of the Cleveland Clinic. Engage in real-life case studies and interactive forums designed to foster collaboration and strategic partnerships.
Don’t miss this opportunity to elevate your HR strategies and connect with peers in the healthcare sector.
Learn more now here: https://tinyurl.com/3ae7n3v5
Join us for the PharmaMarketing Summit 2026, an exclusive, invitation-only event tailored for senior pharmaceutical marketing executives and innovative service providers. This premier summit will feature industry leaders sharing insights on the latest trends and strategies in pharmaceutical marketing.
Key Speakers:
· Michael Silk, Vice President, Commercial Oncology, AbbVie
· Devika Gupta, Executive Director, Global Market Access, Immunology, Merck
· Kishan Kumar, Executive Director, Head of Marketing, Malignant Hematology, Novartis
The summit offers a unique opportunity for networking and collaboration, bringing together thought leaders to address key challenges and share innovative solutions in the pharmaceutical landscape. Don’t miss this chance to enhance your s…
The past few years for the TCR community have been dynamic. Approvals have signalled a viable path to commercialization, while a wave of company closures highlight the deep-rooted challenges in the current development processes. The message is clear: success is not guaranteed at approval. Addressing manufacturing costs, durability and long-term commercial viability is now mission critical for developers of TCR-based cell and biologic therapies.
Spanning the full therapeutic landscape, including TCR-T, TCR mimetics, TCR-TCEs and TCR bispecifics, the 7th TCR-Based Therapies Summit cuts through the noise to focus exclusively on the challenges most acutely impacting the TCR field today. Connect with and hear directly from senior leaders driving progress at the forefront of the field, including…
The 4th Nasal Formulation and Delivery Summit is uniting formulation, delivery, and product development leaders from across pharma and biotech to advance the development of safe, effective, and commercially viable intranasal therapies. As intranasal delivery gains validation across systemic, CNS, and emergency-use indications, the pressure to optimize formulations, align drug–device strategies, and generate predictive preclinical and clinical data has never been greater.
In an era of accelerating approvals, expanding modalities, and heightened regulatory scrutiny, teams must move beyond proof-of-concept to ensure intranasal programs are scalable, translatable, and fit for commercialization. Success now depends on solving formulation and delivery challenges early, while designing deve…
The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.
The 5th Circular and Self-Amplifying RNA Therapeutics Summit is the only industry forum dedicated exclusively to translating circRNA and saRNA into durable, IND-ready medicines. As the RNA field moves beyond linear mRNA, these next-generation modalities are emerging as the solution to short-lived expression, high dosing requirements, and limited therapeutic reach.
With first-in-human trials now underway, increasing regulatory engagement, and expanding applications across oncology, autoimmune disease, and in vivo CAR-T, 2026 represents a critical inflection point. Developers must now prove not just promise, but performance, from durability and immunogenicity control to delivery, manufacturability, and IP strategy.
Held in Boston from May 26–28, 2026, this summit brings together senior leade…
The 9th Annual Global Clinical Trials Connect 2026 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, effective and quality…
The UK Biotech Day is a leading event for the UK life sciences sector, bringing together executives and R&D scientists from pharma, biotech, medtech, techbio, investors, lawyers, patent attorneys, CROs, CDMOs, accountants, bankers, executive search agencies and others. Serving as a global gateway, it also connects the UK ecosystem with international partners to drive strategic collaborations through dealmaking, innovation, networking and finding new clients and partners.
The Digi-Tech Pharma & AI 2026 Conference is a leading platform uniting pharmaceutical and technology leaders, healthcare innovators, regulatory authorities and solution providers to explore the evolving digital landscape in pharma. This conference promotes collaboration and knowledge exchange, enabling organizations to embrace innovation, streamline operations, and drive better patient outcomes.This event serves as a dynamic platform to explore the integration of science and technology within the pharmaceutical industry, with a strong emphasis on digital trends, AI and machine learning, digital health ecosystems, collaborative innovation, and patient-centric drug development. Key focus areas include digital drug discovery, clinical trials, data science, big data, informatics, real…
The Global Clinical Trials Connect Conference is a premier platform bringing together global leaders, clinical researchers, regulatory experts, and technology pioneers to discuss the latest innovations, best practices, and challenges in clinical trials. This conference fosters collaborations between industry stakeholders to enhance trial efficiency, regulatory compliance, patient safety, and technological adoption.This event unites experts across the clinical trial ecosystem to drive meaningful conversations on digital transformation, decentralized trials, regulatory pathways, patient engagement, and data-driven insights that are shaping the next era of clinical researchFrom adaptive trial designs to AI-powered analytics, this conference explores the latest trends, breakthrough technol…
01-Jun-2026 - 02-Jun-2026
The Patient Support Programs Canada conference is the premier event for professionals dedicated to advancing patient care and optimizing support programs across the Canadian healthcare landscape. Taking place on June 1-2, 2026 at The Omni King Edward Hotel in Toronto, ON, this highly anticipated event brings together thought leaders and stakeholders from across the bio/pharma industry.
Why Attend?Patient Support Programs (PSPs) are a critical component of the healthcare ecosystem and continue to expand in complexity and strategic importance. This conference addresses the need for Canadian organizations to strengthen compliance, governance, and measurement of their PSPs, while continuing to improve access and patient experience, by uniting likeminded professionals for focused, practical dis…
The Marcus Evans 12th Edition Human Factors and User Experience for Medical Device Design conference taking place in San Diego between June 2-3, will explore risk-based usability assessments, regulatory compliance strategies, AI-driven design enhancements, and human-centered innovation to improve user experience in medical devices. Through expert-led panels, real-world case studies, and interactive workshops, industry leaders will share insights on usability testing, risk mitigation, user-centered design, and digital health integration. Our expert speakers will delve into strategies to enhance product usability, streamline regulatory approvals, or optimize user experience. This event provides the latest strategies, tools, and innovations to advance human factors and UX in medical device de…
Bolstering a Resurgence in Novel Approaches to Target Underlying Pathology, Address Disease Heterogeneity and Restore Hope in a More Transformative Wave of ALS and FTD Therapies.
Uniting ALS Biotech, Pharma and Academia to Accelerate the Next Generation of ALS and FTD Therapeutics.
Strategic moves across the sector-from Eli Lilly's Alchemab-backed ALS expansion to BMS and insistro's genetically driven collaboration and Clene Nanomedicine's regulatory-stage program-underscore the ALS community’s continued commitment to advancing impactful therapies, even in the face of clinical setbacks.
With over 475 therapies in development, and 157 active or enrolling trials, and more than 350 companies actively working in ALS, and a global ALS market projected to grow from USD 667.3M in 2023 to USD 987.…
Achieving precise extrahepatic delivery remains one of the biggest challenges in the LNP field. However, with AbbVie’s acquisition of Capstan Therapeutics and BMS’s acquisition of Orbital Therapeutics, the industry’s confidence in targeted LNPs has never been higher!
Returning to Boston in June 2026, the 5th Extrahepatic Lipid-Based Nanoparticles Delivery Summit is bringing together industry pioneers and leading delivery experts to showcase the latest advances in novel targeting ligands and innovative lipid-based technologies. Across 3 jam-packed days, attendees will gain in-depth technical insights into accelerating the delivery of mRNA, RNA, gene-editing, and cell therapy payloads to extrahepatic tissues, including immune cells, adipose tissues, muscle, and more.
With world-class speaker…
Establish Procurement Excellence for R and D Innovation, Drive Supplier Value and Accelerate Study Timelines Through AI and Strategic Initiatives.
R and D procurement is undergoing a major transformation as organizations shift from transactional buying to strategic, innovation-driven value creation across the development pipeline. Procurement teams are navigating unprecedented complexity: strengthening global sourcing models amid geopolitical instability, extracting true value from CRO and CMO partnerships, integrating AI and orchestration tools to streamline operations, and aligning internal stakeholders around business continuity, speed, and scientific ambition. At the same time, the demands of emerging modalities, digital trial technologies, and evolving supplier ecosystems require more…
Foster Innovation and Collaboration at the 10th Annual Pre-Filled Syringes and Injectable Drug Devices West Coast Conference!
Join us in June 2026 as SAE Media Group's renowned West Coast event returns, bringing together biotech pioneers, pharma leaders, and device innovators to shape the future of injectable drug delivery.
This year's conference will bring a brand NEW focus day followed by the two-day main conference offering an unparalleled platform to explore cutting-edge advances in combination product technology while fostering collaboration between pharma, device developers, and regulators.
What You'll Gain:
Actionable insights to strengthen your drug-device portfolio.Opportunities to network with key players shaping the injectable drug delivery landscape.A future-focused perspective…
Bispecifics and T-cell engagers are redefining the future of solid tumor treatment. With the landmark approvals of tarlatamab and ivonescimab, the spotlight is firmly on these modalities as powerful solutions for long-standing unmet needs. At the same time, the field is rapidly evolving beyond first-generation designs, with innovations in co-stimulation, conditional activation, multispecific engineering, and affinity tuning aimed at deepening response rates while mitigating dose-limiting toxicities.
Innovation is rife within Korea, with companies such as ABL Bio, Novelty Nobility, ABION, and IM Biologics capturing international attention and investment, positioning Korea as a key player in the bispecific and TCE revolution.
To accelerate this momentum, the inaugural World Bispecific and T-…
